Regulatory submission timelines are fixed. Design freeze is non-negotiable. First-off sample failures do not just cost money. They cost approvals.
Your products are not competing with European and Western quality standards.
China is moving ahead. The gap is not capability. The gap is governance.
Medical device founders with electronics backgrounds treat the housing as secondary. It gets approved quickly. Then assembly happens, fitment is off, and the rated performance cannot be validated because the physical product was never properly governed.
The brief was incomplete. Nobody caught it before manufacturing. And at that point, the regulatory clock has already started.
Most medical device tooling failures were decided before steel was cut. They were just not visible yet.
Suppliers chosen on price. Technical capability never verified. Problems surface at trial, after commitment is made.
Design, engineering, tooling, manufacturing each have an owner. The connection between them does not. This is where medical programmes fail.
Early decisions taken without understanding their downstream impact on tooling, trials, and regulatory timelines.
Tooling sourced from China without a governance layer. Suppliers deliver to their standard. Not yours.
Every function has a person. Design, engineering, procurement, quality. Everyone is doing their job.
The gap between functions still exists. Nobody owns the outcome.
When one or two people managing multiple functions, heavy reliance on freelancers and agencies across different stages.
When one person exits, programme momentum goes with them.
Founder managing all vendors directly. Design agency, engineering freelancer, tooling supplier working without a governance layer.
No one is watching the gap. Nobody was hired to.
Governance is not a replacement for your team. It is what makes every team configuration work better.
Design changes keep coming informally after freeze.
Supplier issues surface at trial. Problems discovered at trials.
Regulatory requirements discovered after commitment is made.
Teams handoff between agencies creates an unmanaged gap.
China supplier remains to their standard. Not yours.
Design freeze is real. Every change assessed before approval.
Supplier capability verified before tooling is awarded.
Regulatory timeline built into every governance decision.
One authority holds programme visibility across all stages.
China sourcing under governance. Not open market without accountability.
"We had good people on every part of the programme. The product still did not come out right. And we still are not sure exactly why."
A medical device programme founder. The project is about three years behind where they expected.

"Flawless production and excellent after sales service was provided by the team."

"I am thankful to Mr. Jagdip for helping us save approximately 39 lakhs for our Injection Mould Project."
Diagnostic and imaging equipment
Patient monitoring devices and wearables
Drug delivery and infusion systems
Surgical and intervention instruments
Telemedicine and remote monitoring
AI-enabled medical devices and diagnostics
Regulatory timelines that cannot absorb delays
Design changes still happening informally
First product launch with no governance structure in place
Supplier not independently validated
Programme continuity depending on freelancers
First-off sample failures would carry regulatory consequences
Depending on programme complexity and risk, governance is structured across three levels: LaunchGuard, ToolLock Control, and ToolLock Lite.
See Programme Details →Where do you want to go next
READY TO TALK
Twenty minutes. No quotation.
SEE INDUSTRIES WE GOVERN
See how the same governance principles apply across Appliances, Automotive, and Consumer Electronics.